These medicines can greatly increase the risk of bleeding, so they are used only in very specific situations where the risk of bleeding can be balanced against the risks of not dissolving the blood clot rapidly. Thrombolytics may reduce the incidence of post-thrombotic syndrome in people who are at high risk for this condition.
In this article
This information is produced and provided by the National
Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National
Institute via the Internet web site at http://
.gov or call 1-800-4-CANCER.
WebMD Medical Reference from Healthwise
September 09, 2014
This information is not intended to replace the advice of a doctor.
Healthwise disclaims any liability for the decisions you make based on this